On April 4, 2022, Jeffery Baxter notified ChromaDex Corporation (the Company") of his intention to resign from the board of directors of the Company (the Board") and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board. The effective date of Mr. Baxter's resignation is April 4, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | 0.00% |
|
-9.40% | +88.81% |
Jun. 13 | Chromadex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® | CI |
Jun. 07 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.81% | 205M | |
+35.00% | 51.51B | |
-6.92% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.81% | 26.13B | |
-14.39% | 19.91B | |
+43.15% | 13.71B | |
+30.58% | 12.38B | |
-4.34% | 11.74B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- Jeffery Baxter Notifies His Intention to Resign from Board of ChromaDex